Clavulanate potassium structure
|
Common Name | Clavulanate potassium | ||
---|---|---|---|---|
CAS Number | 61177-45-5 | Molecular Weight | 237.251 | |
Density | N/A | Boiling Point | 545.8ºC at 760 mmHg | |
Molecular Formula | C8H8KNO5 | Melting Point | >1600C (dec) | |
MSDS | Chinese USA | Flash Point | 283.9ºC | |
Symbol |
GHS02, GHS08 |
Signal Word | Danger |
Use of Clavulanate potassiumClavulanate potassium is a potent β-lactamase inhibitor and acts as an antibiotic[1][2]. |
Name | potassium |
---|---|
Synonym | More Synonyms |
Description | Clavulanate potassium is a potent β-lactamase inhibitor and acts as an antibiotic[1][2]. |
---|---|
Related Catalog | |
Target |
β-lactamase[1] |
In Vitro | Clavulanate potassium has weak antibacterial activity against most organisms when administered alone, but given in combination with beta-lactam antibiotics prevents antibiotic inactivation by microbial lactamase[1]. Clavulanate potassium (0.25 mg/L, 0.5 mg/L) causes a relatively slow inhibition of growth, and a higher concentration (1 mg/L) is only marginally more effective than 0.5 mg/L[2]. |
References |
Boiling Point | 545.8ºC at 760 mmHg |
---|---|
Melting Point | >1600C (dec) |
Molecular Formula | C8H8KNO5 |
Molecular Weight | 237.251 |
Flash Point | 283.9ºC |
Exact Mass | 237.003952 |
PSA | 89.90000 |
Storage condition | 2-8°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS02, GHS08 |
---|---|
Signal Word | Danger |
Hazard Statements | H228-H317-H319-H334 |
Supplemental HS | Reacts violently with water., Risk of explosion if heated under confinement. |
Precautionary Statements | P210-P261-P280-P284-P304 + P340-P305 + P351 + P338 |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
Hazard Codes | F,Xn,Xi |
Risk Phrases | 11-42/43-44-36-14 |
Safety Phrases | 8-16-22-36/37-45-43-26 |
RIDADR | UN1325 - class 4.1 - PG 2 - Flammable solids, organic, n.o.s., HI: all |
WGK Germany | 2 |
RTECS | RN6802700 |
HS Code | 2942000000 |
HS Code | 2942000000 |
---|
Antibiotics for acute otitis media: yes or no.
JAMA 313(3) , 294-5, (2015)
|
|
The NOTA Study (Non Operative Treatment for Acute Appendicitis): prospective study on the efficacy and safety of antibiotics (amoxicillin and clavulanic acid) for treating patients with right lower quadrant abdominal pain and long-term follow-up of conservatively treated suspected appendicitis.
Ann. Surg. 260(1) , 109-17, (2014) To assess the safety and efficacy of antibiotics treatment for suspected acute uncomplicated appendicitis and to monitor the long term follow-up of non-operated patients.Right lower quadrant abdominal... |
|
Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial.
JAMA Pediatr. 168(7) , 635-41, (2014) Antimicrobial treatment reduces the symptoms of acute otitis media (AOM). The effect of antimicrobial treatment on the duration of middle ear effusion (MEE) and concomitant hearing impairment is not k... |
Potassium clavulanate |
EINECS 262-640-9 |
MFCD01710901 |
Clavulanic Acid Potassium Salt |
Clavulanate Potassium |